A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative (original) (raw)

A National Canadian Survey of Antithrombotic Therapy After Urgent and Emergent Limb Revascularization

John Harlock

Canadian Journal of Cardiology, 2021

View PDFchevron_right

Antithrombotic Therapy in Peripheral Artery Disease

Graham McClure

Chest, 2012

View PDFchevron_right

Effectiveness and safety of anticoagulant versus antiplatelet therapy in patients after endovascular revascularisation of the lower limb

Natasa Kejzar

Slovenian Medical Journal

View PDFchevron_right

Reducing residual thrombotic risk in patients with peripheral artery disease: impact of the COMPASS trial

Xavier García-moll

Drugs in Context

View PDFchevron_right

Antiplatelet Therapy and Other Interventions after Revascularisation Procedures in Patients with Peripheral Arterial Disease: a Meta-analysis

Martin Prins

European Journal of Vascular and Endovascular Surgery, 2000

View PDFchevron_right

A Review of Antithrombotic Treatment in Critical Limb Ischemia After Endovascular Intervention

Amol Gupta

Cardiology and Therapy, 2019

View PDFchevron_right

Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions

Giuseppe Giugliano

Journal of Cardiovascular Development and Disease, 2023

View PDFchevron_right

Anti-platelet and anti-coagulant therapy in peripheral arterial disease prior to surgical intervention

Mika Burgess

Vascular, 2018

View PDFchevron_right

Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Work...

Stefan Agewall

European Heart Journal - Cardiovascular Pharmacotherapy, 2019

View PDFchevron_right

Thrombotic Risk Factors and Cardiovascular Events after Endovascular Intervention for Peripheral Arterial Disease

Gualtiero Palareti

European Journal of Vascular and Endovascular Surgery, 2011

View PDFchevron_right

The CLEAR (Considering Leading Experts’ Antithrombotic Regimes around peripheral angioplasty) survey: an international perspective on antiplatelet and anticoagulant practice for peripheral arterial endovascular intervention

Pierfrancesco Lapolla

CVIR Endovascular

View PDFchevron_right

Comparative effectiveness review of antiplatelet agents in peripheral artery disease

manesh patel

Journal of the American Heart Association, 2014

View PDFchevron_right

Update on the Management of Peripheral Arterial Disease (PAD)

Gee Putera

Med J Malaysia, 2011

View PDFchevron_right

A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia

Christopher Cox

Journal of Vascular Surgery, 1994

View PDFchevron_right

Comparison of Antiplatelet and Antithrombotic Therapy for Secondary Prevention of Ischemic Stroke in Patients With Peripheral Artery Disease

Po-chao Hsu

Circulation Journal, 2013

View PDFchevron_right

Restenosis is associated with prothrombotic plasma fibrin clot characteristics in endovascularly treated patients with critical limb ischemia

Tomasz Nowakowski

Journal of Thrombosis and Thrombolysis

View PDFchevron_right

High plateletcrit is associated with early loss of patency after open and endovascular interventions for chronic limb ischemia

Nader D. Nader

Journal of Vascular Surgery, 2019

View PDFchevron_right

Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease

Giovanni Cafaro

Annals of Medicine, 2014

View PDFchevron_right

European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases

Miltiadis Matsagkas

Journal of Vascular Surgery, 2023

View PDFchevron_right

Peripheral Arterial Disease - antiplatelet therapy

Debora Karetová

2010

View PDFchevron_right

Management of chronic peripheral artery disease patients with indication for endovascular revascularization

Juraj Madaric

Vasa

View PDFchevron_right

Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease

Alberico Catapano

Atherosclerosis, 2021

View PDFchevron_right

Guided Antithrombotic Therapy: Current Status and Future Research Direction

Jeffrey Weitz

Circulation, 2012

View PDFchevron_right

Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery

Martin Prins

Protocols, 1996

View PDFchevron_right

Comparative effectiveness of endovascular and surgical revascularization for patients with peripheral artery disease and critical limb ischemia

Sreekanth Vemulapalli

American Heart Journal, 2014

View PDFchevron_right

Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy

Christine Espinola-klein

European Heart Journal, 2021

View PDFchevron_right

Peripheral thrombolysis: state of the art

Jonothan Earnshaw

Cardiovascular Surgery, 1995

View PDFchevron_right

Supplemental material for Anti-platelet and anti-coagulant therapy in peripheral arterial disease prior to surgical intervention

Mika Burgess

2018

View PDFchevron_right